The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Cannabis use and risk of schizophrenia: a Mendelian randomization study
Open accessAbstract
Cannabis use is observationally associated with an increased risk of schizophrenia, but whether the relationship is causal is not known. Using a genetic approach, we took 10 independent genetic variants previously identified to associate with cannabis use in 32 330 individuals to determine the nature of the association between cannabis use and risk of schizophrenia. Genetic variants were employed as instruments to recapitulate a randomized controlled trial involving two groups (cannabis users vs nonusers) to estimate the causal effect of cannabis use on risk of schizophrenia in 34 241 cases and 45 604 controls from predominantly European descent. Genetically-derived estimates were compared with a meta-analysis of observational studies reporting ever use of cannabis and risk of schizophrenia or related disorders. Based on the genetic approach, use of cannabis was associated with increased risk of schizophrenia (odds ratio (OR) of schizophrenia for users vs nonusers of cannabis: 1.37; 95% confidence interval (CI), 1.09-1.67; P-value=0.007). The corresponding estimate from observational analysis was 1.43 (95% CI, 1.19-1.67; P-value for heterogeneity =0.76). The genetic markers did not show evidence of pleiotropic effects and accounting for tobacco exposure did not alter the association (OR of schizophrenia for users vs nonusers of cannabis, adjusted for ever vs never smoker: 1.41; 95% CI, 1.09-1.83). This adds to the substantial evidence base that has previously identified cannabis use to associate with increased risk of schizophrenia, by suggesting that the relationship is causal. Such robust evidence may inform public health messages about cannabis use, especially regarding its potential mental health consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Self-citationBowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 3×
“We tested for presence of unmeasured pleiotropy of the genetic instruments using MR-Egger as described by Bowden et al.(11) Essentially, this uses the same principles of testing”
InfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citationMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
A review of instrumental variable estimators for Mendelian randomization
Burgess, S., Small, D. S., & Thompson, S. G. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280215597579 · Cited by 1,764
Calculating statistical power in Mendelian randomization studies.
Brion, M.-J. A., Shakhbazov, K., & Visscher, P. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt179 · Cited by 1,751
Bias due to participant overlap in two‐sample Mendelian randomization
Burgess, S., Davies, N. M., & Thompson, S. G. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21998 · Cited by 1,624
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
Johnson, A. D., Handsaker, R. E., Pulit, S. L., Nizzari, M. M., O'Donnell, C. J., & de Bakker, P. I. W. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn564 · Cited by 1,330
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
Backer, G. D., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-3-57-65 · Cited by 1,267
Burgess, S., Dudbridge, F., & Thompson, S. G. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv017 · Cited by 934
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765
Holmes, M. V., Dale, C. E., Zuccolo, L., Silverwood, R. J., Guo, Y., Ye, Z., Prieto-Merino, D., Dehghan, A., Trompet, S., Wong, A., et al. (2014) · BMJ · doi:10.1136/bmj.g4164 · Cited by 669 · cited 1×
“hypothesis), is not possible for ethical reasons, as it would involve exposing participants to a potentially harmful exposure (a similar scenario to examining whether alcohol protects against risk of cardiovascular disease).(26) In this setting, Mendelian randomization can”
Self-citationPublic health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
Shim, H., Chasman, D. I., Smith, J. D., Mora, S., Ridker, P. M., Nickerson, D. A., Krauss, R. M., & Stephens, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120758 · Cited by 558
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (n.d.) · Open Access CRIS of the University of Bern · doi:10.7892/boris.89711 · Cited by 408
Self-citationDean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 383
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379
Mendelian randomization: where are we now and where are we going?
Burgess, S., Timpson, N. J., Ebrahim, S., & Davey Smith, G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv108 · Cited by 304
Gelernter, J., Kranzler, H. R., Sherva, R., Koesterer, R., Almasy, L., Zhao, H., & Farrer, L. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.034 · Cited by 230
Rabin, R. A., & George, T. P. (2015) · The American Journal on Addictions · doi:10.1111/ajad.12186 · Cited by 203
Corbin, L. J., Richmond, R. C., Wade, K. H., Burgess, S., Bowden, J., Smith, G. D., & Timpson, N. J. (2016) · Diabetes · doi:10.2337/db16-0418 · Cited by 184
Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences
TIEN, A. Y., & ANTHONY, J. C. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199008000-00001 · Cited by 175
Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence
French, L., Gray, C., Leonard, G., Perron, M., Pike, G. B., Richer, L., Séguin, J. R., Veillette, S., Evans, C. J., Artiges, E., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1131 · Cited by 174
Stringer, S., Minică, C. C., Verweij, K. J. H., Mbarek, H., Bernard, M., Derringer, J., van Eijk, K. R., Isen, J. D., Loukola, A., Maciejewski, D. F., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.36 · Cited by 160
Human Laboratory Studies on Cannabinoids and Psychosis
Sherif, M. A., Radhakrishnan, R., D’Souza, D. C., & Ranganathan, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.011 · Cited by 150
Thomas, D. C., Lawlor, D. A., & Thompson, J. R. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.12.005 · Cited by 140
McEvoy, J. P. (2007) · PubMed · Cited by 135
Ross, S. A., Gerstein, H. C., Eikelboom, J. W., Anand, S. S., Yusuf, S., & Paré, G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv083 · Cited by 131
Self-citationYang, B., Kranzler, H. R., Zhao, H., Gruen, J. R., Luο, X., & Gelernter, J. E. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00800.x · Cited by 103
Gage, S. H., Hickman, M., Heron, J., Munafò, M. R., Lewis, G., Macleod, J., & Zammit, S. (2014) · Psychological Medicine · doi:10.1017/s0033291714000531 · Cited by 91
Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender
Dekker, N. L., Meijer, J. H., Koeter, M. W. J., van den Brink, W., van Beveren, N. J. M., GROUP Investigators:, Kahn, R. S., Linszen, D. H., van Os, J., Wiersma, D., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712000062 · Cited by 37
Cited by
Skrivankova, V. W., Richmond, R. C., Woolf, B. A. R., Yarmolinsky, J., Davies, N. M., Swanson, S. A., VanderWeele, T. J., Higgins, J. P. T., Timpson, N. J., Dimou, N., et al. (2021) · JAMA · doi:10.1001/jama.2021.18236 · Cited by 3,994
Recent Developments in Mendelian Randomization Studies
Zheng, J., Baird, D., Borges, M.-C., Bowden, J., Hemani, G., Haycock, P., Evans, D. M., & Smith, G. D. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0128-6 · Cited by 1,147
Burgess, S., & Labrecque, J. A. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0424-6 · Cited by 569
the 23andMe Research Team, Pasman, J. A., The Substance Use Disorders Working Group of the Psychiatric Genomics Consortium, International Cannabis Consortium, Verweij, K. J. H., Gerring, Z., Stringer, S., Sanchez-Roige, S., Treur, J. L., Abdellaoui, A., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0206-1 · Cited by 498
Psychiatric genetics and the structure of psychopathology
Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J., & Kendler, K. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-017-0010-4 · Cited by 398
Metadata
- Authors
- Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith, D. J., Pell, J. P., Sattar, N., Paré, G., & Holmes, M. V.
- Venue
- Molecular Psychiatry
- Published
- 2017-01-24
- Volume
- 23
- Issue
- 5
- Pages
- 1287-1292
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2582094868
- Cited by
- 260
- References
- 40
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.